Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study

EPTB exhibits highly variable disease severity and organ involvement. Treatment initiation is often delayed due to diagnostic challenges. Management is complicated by the frequent occurrence of PR, which can lead to treatment durations exceeding standard recommendations. Clinical scores for treatment response assessment may not be reliably applicable, highlighting the need for alternative biomarkers.

Authors

Institutions

Publication Details

Journal
Infection
Published
2025-03-11
DOI
https://doi.org/10.1007/s15010-025-02500-4
Citations
10
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
13.96

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study

Samuel Rohr, Margarete Scherer, Philipp Schommers, A Hoffmann et al.
10 citations
Infection
Tuberculosis Research and Epidemiology
13.96
article

Clinical heterogeneity and treatment outcomes of extrapulmonary tuberculosis in a low-incidence setting: insights from a prospective cohort study

Samuel Rohr, Margarete Scherer, Philipp Schommers, A Hoffmann, Jakob J Malin, Jan Rybniker, Lena M. Biehl, Jörg Janne Vehreschild, Alexander Simonis, Marie Feldmann, Lena Junker, Angela Klingmüller, Gerd Fätkenheuer, Clara Lehmann, Natalie Funke, Dominic Rauschning, Jonathan Jantsch, Isabelle Suárez, Kirsten Schmidt-Hellerau, Víctor Suárez, Lea Helmhold
article en
10 citations

Abstract

EPTB exhibits highly variable disease severity and organ involvement. Treatment initiation is often delayed due to diagnostic challenges. Management is complicated by the frequent occurrence of PR, which can lead to treatment durations exceeding standard recommendations. Clinical scores for treatment response assessment may not be reliably applicable, highlighting the need for alternative biomarkers.

InfectionVol. 53(5)
Goethe University Frankfurt (DE), University of Cologne (DE), German Center for Infection Research (DE), Evangelisches Krankenhaus Düsseldorf (DE), University Hospital Cologne (DE), Bundeswehrzentralkrankenhaus Koblenz (DE)
Universität zu Köln, Universitätsklinikum Köln
Good health and well-being
Openalex Percentile: Top 1%
Tuberculosis Research and Epidemiology
13.96
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.